4
Changes in Ownership
SpyGlass Pharma, Inc. Filed Acc 0002108044-26-000004
Options or other derivatives
- Director acquired 13,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Khan Bilal Arshad Director | 2026-02-05 | Grant or award · Stock Option (right to buy) | +13,700 | 13,700 | D | ||
Loading xslF345X05/form4-02092026_090210.xml…